Company announcement No. 04/2025 23 January 2025 Transactions in connection with share buyback programmeOn 31 October 2024, ...

The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...

Notification no. 6/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back ...

For companies in the process of listing (or already listed) on Nasdaq Copenhagen or Nasdaq Helsinki, please contact your local Relationship Manager to schedule training sessions. For companies to ...

KITCHENER, ON, Jan. 8, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company's majority-owned ...

Annual Report 2024 FINANCIAL YEAR 2025 27.03.2025 – Election meeting 10.07.2025 – Semi annual Report 2025 24.04.2026 – Annual ...

South Korea has significant potential for offshore wind and is one of the most promising markets in Asia Pacific, with an ambitious target of 14.3GW installed capacity by 2030. The country has pledged ...

(MENAFN- GlobeNewsWire - Nasdaq) The two companies have formed a partnership to jointly develop, build, and operate a carbon capture facility outside of Copenhagen in Denmark. The facility is expected ...

( MENAFN - GlobeNewsWire - Nasdaq) Copenhagen Infrastructure Partners and Friesen Elektra Green energy AG have launched project Anker, a green hydrogen production facility in Sande, Lower Saxony, ...

Nasdaq (Nasdaq: NDAQ) today announced that Nasdaq Helsinki launches a new segment for ETN (Exchange Traded Notes) products. ETNs are exchange listed debt instruments issued ...

Company AnnouncementNet sales of DARZALEX® in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson & ...

COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, ...